PR Newswire
BUENA, N.J., March 1, 2017
BUENA, N.J., March 1, 2017 /PRNewswire/ -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30 pm ET on Tuesday, March 7, 2017 to discuss the 4th quarter and year end 2016 results.
The Company invites you to listen to the call by dialing 1-888-346-3479. International participants should call 1-412-902-4260. Canadian participants should call 1-855-669-9657. Participants should ask to be joined into the Teligent, Inc. call.
This call is being webcast by MultiVu (a PR Newswire Company) and can be accessed in the Investor Relations Section of Teligent Inc.'s website at www.teligent.com.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
Contact: |
Jenniffer Collins |
Teligent, Inc. | |
(856) 697-4379 | |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/teligent-inc-to-hold-conference-call-for-4th-quarter-and-year-end-2016-results-300415631.html
SOURCE Teligent, Inc.
We use cookies to tailor your experience, measure site performance and present relevant offers and advertisements. By clicking ‘Accept’ or any content on this site, you agree that cookies can be placed on your browser. You can view our privacy policy to learn more.
If you would like to get more data, alerts and access to Real Vision videos, join us as an Insider Tracking Advantage Ultra member